Kwak Seo-Young, Yang Ji-Sook, Kim Bu-Yeon, Bae In Hwa, Han Young-Hoon
Biochim Biophys Acta. 2014 Mar;1843(3):508-16. doi: 10.1016/j.bbamcr.2013.11.021.
MicroRNAs (miRNAs) play an important role in various stages of tumor progression. miR-494, which we had previously identified as a miRNA induced by ionizing radiation (IR) in the glioma cell line U-251, was observed to enhance invasion of U-251 cells by activating MMP-2. The miR-494-induced invasive potential was accompanied by, and dependent on, epidermal growth factor receptor (EGFR) upregulation and the activation of its downstream signaling constituents, Akt and ERK. The upregulation of EGFR by miR-494 involved the suppression of lysosomal protein turnover. Among the putative target proteins tested, p190B RhoGAP (p190B) was downregulated by miR-494, and its reduced expression was responsible for the increase in EGFR expression. A reporter assay using a luciferase construct containing p190B 3'-untranslated region (3'UTR) confirmed that p190B is a direct target of miR-494. Downregulation of p190B by small interfering RNA (siRNA) transfection closely mimicked the outcomes of miR-494 transfection, and showed increased EGFR expression, MMP-2 secretion, and invasion. Ectopic expression of p190B suppressed the miR-494-induced EGFR upregulation and invasion promotion, thereby suggesting that p190B depletion is critical for the invasion-promoting action of miR-494. Collectively, our results suggest a novel function for miR-494 and its potential application as a target to control invasiveness in cancer therapy.
微小RNA(miRNA)在肿瘤进展的各个阶段发挥着重要作用。我们之前在胶质瘤细胞系U-251中鉴定出miR-494是一种由电离辐射(IR)诱导的miRNA,观察发现它通过激活基质金属蛋白酶-2(MMP-2)来增强U-251细胞的侵袭能力。miR-494诱导的侵袭潜能伴随着表皮生长因子受体(EGFR)的上调及其下游信号成分Akt和ERK的激活,并且依赖于它们。miR-494导致的EGFR上调涉及溶酶体蛋白周转的抑制。在测试的假定靶蛋白中,p190B RhoGAP(p190B)被miR-494下调,其表达降低导致了EGFR表达的增加。使用含有p190B 3'非翻译区(3'UTR)的荧光素酶构建体进行的报告基因检测证实p190B是miR-494的直接靶标。通过小干扰RNA(siRNA)转染下调p190B紧密模拟了miR-494转染的结果,并显示出EGFR表达增加、MMP-2分泌增加和侵袭增强。p190B的异位表达抑制了miR-494诱导的EGFR上调和侵袭促进作用,从而表明p190B的缺失对于miR-494的侵袭促进作用至关重要。总体而言,我们的结果揭示了miR-494的新功能及其作为癌症治疗中控制侵袭性靶点的潜在应用。